Toxoplasmosis: A global threat

Journal of Global Infectious Diseases

Volumn 3, Issue 3, 2011, Pages 281-284

  Furtado, João M ^a   Smith, Justine R ^a   Belfort Jr , Rubens ^b   Gattey, Devin ^a   Winthrop, Kevin L ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Congenital toxoplasmosis; Ocular toxoplasmosis; Toxoplasmic encephalitis

Indexed keywords

COTRIMOXAZOLE; FOLINIC ACID; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PREDNISOLONE; PYRIMETHAMINE; SULFADIAZINE;

AIDS PATIENT; ASYMPTOMATIC INFECTION; BLINDNESS; CLINICAL FEATURE; CONFERENCE PAPER; CONGENITAL TOXOPLASMOSIS; ENCEPHALITIS; EYE INFECTION; HEALTH EDUCATION; HUMAN; HYGIENE; IMMUNOCOMPROMISED PATIENT; INFECTION PREVENTION; LABORATORY DIAGNOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENT INFECTION; SERODIAGNOSIS; SEROPREVALENCE; TACHYZOITE; TOXOPLASMA GONDII; TOXOPLASMIC ENCEPHALITIS; TOXOPLASMOSIS; VERTICAL TRANSMISSION; VISUAL IMPAIRMENT;

EID: 80051872269     PISSN: 0974777X     EISSN: 09748245     Source Type: Journal    
DOI: 10.4103/0974-777X.83536     Document Type: Conference Paper

References (53)

1. Holland GN, O'Connor RR Jr, Remington JS. Toxoplasmosis. In: Pepose JS, Holland GN, Wilhelmus KR, editors. Ocular Infection and Immunity. St. Louis: Mosby-Year Book, Inc; 1996. p. 1183-223.
2. Contini C. Clinical and diagnostic management of toxoplasmosis in the immunocompromised patient. Parassitolog 2008;50:45-50.
3. Jones JL, Dubey JP. Waterborne toxoplasmosis-recent developments. Exp Parasitol 2010;124:10-25.
4. Bowie WR, King AS, Werker DH, Isaac-Renton JL, Bell A, Eng SB, et al. Outbreak of toxoplasmosis associated with municipal drinking water: The BC Toxoplasma Investigation Team. Lancet 1997;350:173-7. (Pubitemid 27303624)
5. Palanisamy M, Madhavan B, Balasundaram MB, Andavar R, Venkatapathy N. Outbreak of ocular toxoplasmosis in Coimbatore, India. Indian J Ophthalmol 2006;54:129-31. (Pubitemid 43936963)
6. Balasundaram MB, Andavar R, Palaniswamy M, Venkatapathy N. Outbreak of acquired ocular toxoplasmosis involving 248 patients. Arch Ophthalmol 2010;128:28-32.
7. de Moura L, Bahia-Oliveira LM, Wada MY, Jones JL, Tuboi SH, Carmo EH, et al. Waterborne toxoplasmosis, Brazil, from field to gene. Emerg Infect Di 2006;12:326-9.
8. Choi WY, Nam HW, Kwak NH, Huh W, Kim YR, Kang MW, et al. Foodborne outbreaks of human toxoplasmosis. J Infect Dis 1997;175:1280-2. (Pubitemid 27176530)
9. Montoya JG, Remington JS. Management of Toxoplasma gondii infection during pregnancy. Clin Infect Dis 2008;47:554-66.
10. Derouin F, Pelloux H. Prevention of toxoplasmosis in transplant patients. Clin Microbiol Infect 2008;14:1089-101.
11. Black MW, Boothroyd JC. Lytic cycle of Toxoplasma gondii. Microbiol Mol Biol Rev 2000;64:607-23.
12. Montoya JG, Remington JS. Toxoplasma gondii. In: Mandell GL, Bennett JE, Dolin RF, editors. Principles and Practice of Infectious Diseases. 5 th ed. Philadelphia: Churchill Livingstone; 2000. p. 2858-88.
13. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004;363:1965-76. (Pubitemid 38759657)
14. Courret N, Darche S, Sonigo P, Milon G, Buzoni-Gatel D, Tardieux I. CD11c-and CD11b-expressing mouse leukocytes transport single Toxoplasma gondii tachyzoites to the brain. Blood 2006;107:309-16. (Pubitemid 43053557)
15. Lambert H, Hitziger N, Dellacasa I, Svensson M, Barragan A. Induction of dendritic cell migration upon Toxoplasma gondii infection potentiates parasite dissemination. Cell Microbiol 2006;8:1611-23. (Pubitemid 44350020)
16. Silveira C, Vallochi AL, Rodrigues da Silva U, Muccioli C, Holland GN, Nussenblatt RB, et al. Toxoplasma gondii in the peripheral blood of patients with acute and chronic toxoplasmosis. Br J Ophthalmol 2011;95:396-400.
17. Sibley LD, Boothroyd JC. Virulent strains of Toxoplasma gondii comprise a single clonal lineage. Nature 1992;359:82-5.
18. Khan A, Fux B, Su C, Dubey JP, Darde ML, Ajioka JW, et al. Recent transcontinental sweep of Toxoplasma gondii driven by a single monomorphic chromosome. Proc Natl Acad Sci USA 2007;104:14872-7. (Pubitemid 350003235)
19. Klaren VN, Kijlstra A. Toxoplasmosis, an overview with emphasis on ocular involvement. Ocul Immunol Inflamm 2002;10:1-26. (Pubitemid 36042843)
20. Shin DW, Cha DY, Hua QJ, Cha GH, Lee YH. Seroprevalence of Toxoplasma gondii infection and characteristics of seropositive patients in general hospitals in Daejeon, Korea. Korean J Parasitol 2009;47:125-30.
21. Xiao Y, Yin J, Jiang N, Xiang M, Hao L, Lu H, et al. Seroepidemiology of human Toxoplasma gondii infection in China. BMC Infect Dis 2010;10:4.
22. Kamani J, Mani AU, Egwu GO, Kumshe HA. Seroprevalence of human infection with Toxoplasma gondii and the associated risk factors, in Maiduguri, Borno state, Nigeria. Ann Trop Med Parasitol 2009;103:317-21.
23. Swai ES, Schoonman L. Seroprevalence of Toxoplasma gondii infection amongst residents of Tanga district in north-east Tanzania. Tanzan J Health Res 2009;11:205-9.
24. Fromont EG, Riche B, Rabilloud M. Toxoplasma seroprevalence in a rural population in France: Detection of a household effect. BMC Infect Dis 2009;9:76.
25. Silveira C, Belfort R Jr, Burnier M Jr, Nussenblatt R. Acquired toxoplasmic infection as the cause of toxoplasmic retinochoroiditis in families. Am J Ophthalmol 1988;106:362-4.
26. Jones JL, Kruszon-Moran D, Sanders-Lewis K, Wilson M. Toxoplasma gondii infection in the United States, 1999-2004, decline from the prior decade. Am J Trop Med Hyg 2007;77:405-10. (Pubitemid 351844310)
27. Jones JL, Holland GN. Annual burden of ocular toxoplasmosis in the US. Am J Trop Med Hyg 2010;82:464-5.
28. Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson MA, Roy SL, et al. Foodborne illness acquired in the United States-major pathogens. Emerg Infect Dis 2011;17:7-15.
29. Mercier A, Devillard S, Ngoubangoye B, Bonnabau H, Bañuls AL, Durand P, et al. Additional haplogroups of Toxoplasma gondii out of Africa: Population structure and mouse-virulence of strains from Gabon. PLoS Negl Trop Dis 2010;4:e876.
30. Khan A, Jordan C, Muccioli C, Vallochi AL, Rizzo LV, Belfort R Jr, et al. Genetic divergence of Toxoplasma gondii strains associated with ocular toxoplasmosis, Brazil. Emerg Infect Dis 2006;12:942-9. (Pubitemid 43848416)
31. Glasner PD, Silveira C, Kruszon-Moran D, Martins MC, Burnier Júnior M, Silveira S, et al. An unusually high prevalence of ocular toxoplasmosis in southern Brazil. Am J Ophthalmol 1992;114:136-44.
32. Holland GN. Ocular toxoplasmosis: A global reassessment. Part II: Disease manifestations and management. Am J Ophthalmol 2004;137:1-17. (Pubitemid 38045181)
33. Holland GN, Lewis KG. An update on current practices in the management of ocular toxoplasmosis. Am J Ophthalmol 2002;134:102-14. (Pubitemid 34722718)
34. Rothova A. Ocular manifestations of toxoplasmosis. Curr Opin Ophthalmol 2003;14:384-8. (Pubitemid 38333577)
35. Holland GN, Engstrom RE Jr, Glasgow BJ, Berger BB, Daniels SA, Sidikaro Y, et al. Ocular toxoplasmosis in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol 1988;106:653-67. (Pubitemid 19009919)
36. Bosch-Driessen LE, Berendschot TT, Ongkosuwito JV, Rothova A. Ocular toxoplasmosis: clinical features and prognosis of 154 patients. Ophthalmology 2002;109:869-78. (Pubitemid 34465218)
37. Holland GN, Crespi CM, ten Dam-van Loon N, Charonis AC, Yu F, Bosch-Driessen LH, et al. Analysis of recurrence patterns associated with toxoplasmic retinochoroiditis. Am J Ophthalmol 2008;145:1007-13.
38. Luft BJ, Chua A. Central nervous system toxoplasmosis in HIV pathogenesis, diagnosis, and therapy. Curr Infect Dis Re 2000;2:358-62.
39. Luft BJ, Remington JS. Toxoplasmic encephalitis in AIDS. Clin Infect Dis 1992;15:211-22.
40. Montoya JG, Remington JS. Toxoplasmosis of the central nervous system. In: Pepose PK, Remington JS, editors. Defense of the brain: Current concepts in the immunopathogenesis and clinical aspects of CNS infections. Boston: Blackwell Scientific 1997. p. 163-88.
41. Lopez A, Dietz VJ, Wilson M, Navin TR, Jones JL. Preventing congenital toxoplasmosis. MMWR Recomm Rep 2000;49:59-68.
42. Vasconcelos-Santos DV, Machado Azevedo DO, Campos WR, Oréfice F, Queiroz-Andrade GM, Carellos EV, et al. Congenital toxoplasmosis in southeastern Brazil: Results of early ophthalmologic examination of a large cohort of neonates. Ophthalmology 2009;116:2199-205, e1.
43. Villena I, Ancelle T, Delmas C, Garcia P, Brezin AP, Thulliez P, et al. Congenital toxoplasmosis in France in 2007: First results from a national surveillance system. Euro Surveill 2010;24:15.
44. Havelaar AH, Kemmeren JM, Kortbeek LM. Disease burden of congenital toxoplasmosis. Clin Infect Dis 2007;44:1467-74. (Pubitemid 46801592)
45. Kemmeren J, Mangen M-J, Duynhoven YV, Havelaar A. Priority setting of foodborne pathogens-disease burden and costs of selected enteric pathogens. Report no. 330080001.: Bilthoven: National Institute for Public Health and the Environment; 2006.
46. Tan HK, Schmidt D, Stanford M, Teär-Fahnehjelm K, Ferret N, Salt A, Gilbert R, et al. Risk of visual impairment in children with congenital toxoplasmic retinochoroiditis. Am J Ophthalmol 2007;144:48-653.
47. Gilbert RE, Freeman K, Lago EG, Bahia-Oliveira LM, Tan HK, Wallon M, et al. Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe. PLoS Negl Trop Dis 2008;2:e277.
48. Montoya JG. Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis. J Infect Dis 2002;185:S73-82. (Pubitemid 34142832)
49. Gras L, Gilbert RE, Wallon M, Peyron F, Cortina-Borja M. Duration of the IgM response in women acquiring Toxoplasma gondii during pregnancy: Implications for clinical practice and cross-sectional incidence studies. Epidemiol Infect 2004;132:541-8. (Pubitemid 38714129)
50. Moshfeghi DM, Dodds EM, Couto CA, Santos CI, Nicholson DH, Lowder CY, et al. Diagnostic approaches to severe, atypical toxoplasmosis mimicking acute retinal necrosis. Ophthalmology 2004;111:716-25. (Pubitemid 38429669)
51. Jones JL, Krueger A, Schulkin J, Schantz PM. Toxoplasmosis prevention and testing in pregnancy, survey of obstetrician-gynaecologists. Zoonoses Public Health 2010;57:27-33.
52. Jones JL, Ogunmodede F, Scheftel J, Kirkland E, Lopez A, Schulkin J, et al. Toxoplasmosis-related knowledge and practices among pregnant women in the United States. Infect Dis Obstet Gynecol 2003;11:139-45. (Pubitemid 37553422)
53. Silveira C, Belfort R Jr, Muccioli C, Holland GN, Victora CG, Horta BL, et al. The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. Am J Ophthalmol 2002;134:41-6. (Pubitemid 34722708)